Previously, we reported the involvement of fibroblasts in bone erosion in cholesteatoma mediated via RANKL signaling4; therefore, we focused on pathogenic nonimmune cells, such as fibroblasts or keratinocytes, in the present study. The gene discussed is TNFSF11; the disease is cholesteatoma.